Cara Therapeutics (CARA) Earnings Date, Estimates & Call Transcripts

→ Now Open: Crypto emergency update (From InvestorPlace) (Ad)

Free CARA Stock Alerts

$0.69

-0.04 (-5.48%)

(As of 04/18/2024 ET)

Compare

Upcoming Earnings Date: May. 20Estimated
Actual EPS (Mar. 4): -$0.59 Missed By -$0.02
Consensus EPS (Mar. 4): -$0.57

Read Call Transcript

Listen to Call

Earnings Per Share Revenue

CARA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

CARA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

Cara Therapeutics Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2024	1	($0.44)	($0.44)	($0.44)
Q2 2024	1	($0.50)	($0.50)	($0.50)
Q3 2024	1	($0.43)	($0.43)	($0.43)
Q4 2024	1	($0.22)	($0.22)	($0.22)
FY 2024	4	($1.59)	($1.59)	($1.59)

CARA Earnings Date and Information

Cara Therapeutics last issued its earnings results on March 4th, 2024. The biopharmaceutical company reported ($0.59) earnings per share for the quarter, missing the consensus estimate of ($0.57) by $0.02. The business had revenue of $3 million for the quarter, compared to analyst estimates of $2.34 million. Cara Therapeutics has generated ($2.18) earnings per share over the last year (($2.18) diluted earnings per share). Earnings for Cara Therapeutics are expected to grow in the coming year, from ($1.03) to ($0.95) per share. Cara Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off prior year's report dates.

Cara Therapeutics Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
5/20/2024 Estimated)	-	-	-	-	-	-	-
3/4/2024	Q4 2023	($0.57)	($0.59)	($0.02)	($0.59)	$2.34 million	$3.00 million
11/13/2023	Q3 2023	($0.53)	($0.52)	+$0.01	($0.52)	$8.80 million	$4.87 million
8/7/2023	Q2 2023	($0.56)	($0.58)	($0.02)	($0.58)	$6.49 million	$6.93 million
5/15/2023	Q1 2023	($0.53)	($0.49)	+$0.04	($0.49)	$5.05 million	$6.17 million
3/6/2023	Q4 2022	($0.33)	($0.56)	($0.23)	($0.56)	$14.03 million	$3.26 million
11/7/2022	Q3 2022	($0.42)	($0.43)	($0.01)	($0.43)	$8.39 million	$10.81 million
Get the Latest News and Ratings for CARA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cara Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
8/8/2022	Q2 2022	($0.28)	($0.08)	+$0.20	($0.08)	$21.28 million	$23.00 million
5/9/2022	Q1 2022	($0.56)	($0.52)	+$0.04	($0.52)	$15.82 million	$4.79 million
3/1/2022	Q4 2021	($0.50)	($0.63)	($0.13)	($0.63)	$3.62 million	$0.82 million
11/7/2021	Q3 2021	($0.36)	($0.02)	+$0.34	($0.02)	$15.74 million	$20.27 million
8/8/2021	Q2 2021	($0.55)	($0.61)	($0.06)	($0.61)	-	-
5/9/2021	Q1 2021	($0.59)	($0.47)	+$0.12	($0.47)	$10.15 million	$1.94 million

Cara Therapeutics Earnings - Frequently Asked Questions

When is Cara Therapeutics's earnings date?: Cara Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 20th, 2024 based off last year's report dates. Learn more on CARA's earnings history.
Did Cara Therapeutics beat their earnings estimates last quarter?: In the previous quarter, Cara Therapeutics (NASDAQ:CARA) missed the analysts' consensus estimate of ($0.57) by $0.02 with a reported earnings per share (EPS) of ($0.59). Learn more on analysts' earnings estimate vs. CARA's actual earnings.
How can I listen to Cara Therapeutics's earnings conference call?: The conference call for Cara Therapeutics's latest earnings report can be listened to online. Listen to Conference Call

How can I read Cara Therapeutics's conference call transcript?: The conference call transcript for Cara Therapeutics's latest earnings report can be read online. Read Transcript
How much revenue does Cara Therapeutics generate each year?: Cara Therapeutics (NASDAQ:CARA) has a recorded annual revenue of $20.97 million.
How much profit does Cara Therapeutics generate each year?: Cara Therapeutics (NASDAQ:CARA) has a recorded net income of -$118.51 million. CARA has generated -$2.18 earnings per share over the last four quarters.
What is Cara Therapeutics's EPS forecast for next year?: Cara Therapeutics's earnings are expected to grow from ($1.03) per share to ($0.95) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:

Earnings Tools:

Earnings By Country:

Latest Articles:

This page (NASDAQ:CARA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Cara Therapeutics (CARA) Earnings Date, Estimates & Call Transcripts

CARA Earnings Estimates and Actuals by Quarter

CARA Estimated and Actual Revenue by Quarter

Cara Therapeutics Analyst EPS Estimates

CARA Earnings Date and Information

Cara Therapeutics Earnings History by Quarter

Cara Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cara Therapeutics (CARA) Earnings Date, Estimates & Call Transcripts

Earnings Summary

CARA Earnings Estimates and Actuals by Quarter

CARA Estimated and Actual Revenue by Quarter

Cara Therapeutics Analyst EPS Estimates

CARA Earnings Date and Information

Cara Therapeutics Earnings History by Quarter

Cara Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat